Disparities in breast cancer care in Colombia: systematic review
Article Sidebar
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Societal impact
Main Article Content
Abstract
Objective: To determine the existence of disparities in access for diagnosis and treatment in women diagnosed with breast cancer in Colombia, and to describe the main associated risk factors.
Methodology: A systematic search was conducted with the terms “Breast neoplasms” AND “Health disparities” OR “Health status disparities” OR “Socioeconomic factors” AND “Colombia”, in the Pubmed databases (Medline), Scielo, Cochrane, EBSCO, Ovid, Elsevier, Lilacs, Imbiomed, in Spanish, English, and Portuguese, published from January 1, 2000 back to October 31, 2019.
Results: 14 publications were selected for the writing of the manuscript. It was identified that the socioeconomic level, the level of education and the type of insurance, in most of the studies, showed significant association to disparities in the disease. They also had variable effects on the risk of breast cancer and an impact in its early detection and treatment. These factors influence the full survival of the patient and their becoming disease-free.
Conclusions: Health disparities of patients with breast cancer in Colombia are identified. Factors such as type of insurance, socioeconomic level, educational level were identified, which impact the delay in diagnosis and worsen the clinical condition and the quality of life of the patients.
Article Details
References
Cancer today [Internet]. [citado el 26 octubre de 2019]. Disponible en: http://gco.iarc.fr/today/ home.
Organización Mundial de la Salud. Cáncer: datos y cifras [Internet]. 2017 [citado 2017 abr. 25]. Disponible en: https://www.who.int/mediacentre/factsheets/fs297/es/.
Homedes N, Ugalde A. Las reformas de salud neoliberales en América Latina: una visión crítica a través de dos estudios de caso. Rev Panam Salud Pública. 2005; 17(3):210–20.
WHO. 170-colombia-fact-sheets.pdf [Internet]. [citado el 24 de mayo de 2020]. Disponible en: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf
OMS. Nota descriptiva N.° 297 [Internet]. 2015 [citado 2016 feb. 10]. Disponible en:https:// www.who.int/mediacentre/factsheets/fs297/es/.
Dane Colombia. Estadisticas Vitales [Internet]. 2019 [citado el 24 de mayo de 2020]. Disponible en: https://www.dane.gov.co/files/investigaciones/poblacion/bt_estadisticasvitales_IIItrim_2019pr-
-diciembre-2019.pdf.
International Agency for Research on Cancer. World Cancer Report 2014. Lyon, Francia: International Agency for Research on Cancer; 2014.
Congreso de la República de Colombia. Ley 1384 de 2010, Ley Sandra Ceballos [Internet]. [citado 20 de octubre de 2015]. Disponible en: http://www.alcaldiabogota.gov.co/sisjur/normas/ Norma1.jsp?i=39368.
Velásquez LC, Carrasquilla G, Roca S. Equidad en el acceso al tratamiento para el cáncer de
mama en Colombia. Salud Pública México. 2009; 51:s246–53.
Melnyk BM, Fineout-Overholt E. Making the case for evidence-based practice. In: Melnyk BM, Fineout-Overholt E. Evidence-based practice in nursing & healthcare. A guide to best practice. Philadelphia: Lippincot Williams & Wilkins. 2005. p. 3-24.
STROBE Statement: Home [Internet]. Strobe Statement [Internet]. [citado el 18 de julio de 2021]. Disponible en: https://www.strobe-statement.org/index.php?id=strobe-home
Jung HM, Lee JS, Lairson DR, Kim Y. The effect of national cancer screening on disparity reduction in cancer stage at diagnosis by income level. Plos One. 2015; 10(8):0136036-0136036.
Ministerio de la Protección Social de Colombia, Instituto Nacional de Cancerología. Modelo para el control del cáncer en Colombia [Internet]. 2006 [citado 2016 mar. 20]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists /BibliotecaDigital/RIDE/IA/INCA/Modelo-para-elcontrol- cancer-colombia.pdf.
González-Rossetti A, Mogollón O. La reforma de salud y la seguridad social en Colombia. El desastre del modelo económico. Bogotá D. C.: Biblioteca Jurídica; 1999.
Armada F, Muntaner C, Navarro V. Health and social security reform in Latin America: The covergence of the World Health Organization, the World Bank and transnational corporations. International Journal of Health Services. 2001; 31(4):729-68.
Richards M, Westcombe M, Love SB, Littlejohns P, Ramirez J. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999; 353(9159):1119–26.
Goddard M, Smith P. Equity of access to health care services: Theory and evidence from the UK. Soc Sci Med. 2001; 53(9):1149-62.
Egurrola-Pedraza JA, Gómez-Wolff LR, Ossa-Gómez CA, Sánchez-Jiménez V, Herazo-Maya F, García-García HI. Diferencias en supervivencia debidas al aseguramiento en salud en pacientes con cáncer de mama atendidas en un centro oncológico de referencia en Medellín, Colombia. Cad Saúde Pública Online. 2018; 34(12):e00114117–e00114117.
Sánchez G, Niño CG, Estupiñán AC. Determinantes del tratamiento oportuno en mujeres con cáncer de mama apoyadas por seis organizaciones no gubernamentales en Colombia. Rev Fac Nac Salud Pública. 2016; 34(3):297–305.
Arias-Ortiz NE, de Vries E. Health inequities and cancer survival in Manizales, Colombia: a population-based study. Colomb Med. 2018; 49(1):63–72.
González-Mariño MA. Causas de muerte por cáncer de mama en Colombia. Rev Salud Pública Bogota. 2016; 18(3):344–53.
Bravo LE, García LS, Carrascal E, Rubiano J. Burden of breast cancer in Cali, Colombia: 1962 2012. Salud Publica Mex. 2014; 56(5):448–56.
de Vries E, Arroyave I, Pardo C, Wiesner C, Murillo R, Forman D, et al. Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998–2007. J Epidemiol Community Health. 2015; 69(5):408–15.
Font-González A, Piñeros M, de Vries E. Self-reported early detection activities for breast cáncer in Colombia in 2010: Impact of socioeconomic and demographic characteristics. Salud Pública Mex. 2013; 55(4):368–78.
Justo N, Wilking N, Jönsson B, Luciani S, Cazap E. A review of breast cancer care and outcomes in Latin America. Oncologist. 2013; 18(3):248–56.
Bay G, Jaspers Faijer D. Latin American and Caribbean demographic observatory: Population projection. Quito, Ecuador: Latin American and Caribbean Demographic Centre, 2007.
United Nations Statistics Division. Gross domestic product and gross domestic product per capita [Internet]. [citado el 20 de julio de 2020]. Disponible en: https://data.un.org/_Docs/SYB/ PDFs/SYB62_230_201904_GDP%20and%20GDP%20Per%20Capita.pdf
United Nations Statistics. Human development indices: A statistical update 2009 [Internet].
[citado el 20 de julio de 2020]. Disponible en: http://data.un.org/DocumentData.aspx?id 185#15. AccessedAugust1,2009.
Pedraza AM, Pollán M, Pastor-Barriuso R, Cabanes A. Disparities in breast cancer mortality trends in a middle income country. Breast Cancer Res Treat. 2012; 134(3):1199–207.
Baena A, Almonte M, Valencia ML, Martínez S, Quintero K, Sánchez GI. [Trends and social
indicators of both mortality breast cancer and cervical cancer in Antioquia, Colombia, 2000- 2007]. Salud Publica Mex. 2011; 53(6):486–92.
Piñeros M, Sánchez R, Perry F, García OA, Ocampo R, Cendales R. Demoras en el diagnóstico y tratamiento de mujeres con cáncer de mama en Bogotá, Colombia. Salud Pública Méx. 2011; 53(6):478–85.
Charry LC de, Carrasquilla G, Roca S. [Equity regarding early breast cancer screening according to health insurance status in Colombia]. Rev Salud Publica Bogota Colomb. 2008; 10(4):571–82.
Salas C, Grisales H. Calidad de vida y factores asociados en mujeres con cáncer de mama en Antioquia, Colombia. Rev Panam Salud Pública. 2010; 28(1):9–18.
Javier Idrovo Á. Capital social, muertes violentas y mortalidad por cáncer en Colombia: una
aproximación poblacional. Rev Salud Pública. 2006; 8(1):38–41.